IS THERE A MINIMALLY INVASIVE DAY CASE OPERATION TO TREAT LUTS SECONDARY TO BPH AND AVOID SEXUAL DYSFUNCTION? UROLIFT A CASE REPORT

Urolift as a Day Case Operation to Treat LUTS and Sexual Dysfunction; A Case Report

A 75-year-old Caucasian male with a prolonged history of lower urinary tract symptoms and sexual dysfunction was referred to the urology department. Assessment revealed a diagnosis of benign prostatic hypertrophy (BPH) and the patient was reassessed by flexible cystoscopy revealing a large occlusive 80 cc prostate. Baseline symptoms of BPH were measured using the International Prostate Symptom Score (IPSS), urinary function was quantified by measuring post-void residual (PVR) volume and QMAX flow rates were also recorded. The patient underwent the UroLift procedure and urological parameters were reassessed at 4 months post-operatively. There was an improvement in the patients IPSS by 14 points (IPSS Before = 22, at 4 months = 8), with a reduction in quality of life by 3 points (QoL before = 5, at 4 months = 2). PVR volume decreased by almost a third (29.4 %) (Before = 390 mL, at 4 months = 275 mL) and QMAX improved by 8 mL/s (Before = 14 mL/s, at 4 months = 22 mL/s). The patient reported a slight improvement in sexual function (IIEF-5 Before = 14, at 4 months = 15) and was very satisfied with the result. The improvement in IPSS, PVR volume and QMAX show Urolift is an appropriate treatment for symptomatic BPH.

1. Jones P, Rajkumar GN, Rai BP, et al. Medium-term outcomes of Urolift (minimum 12 months follow-up): evidence from a systematic review. Urology 2016;97:20–24. http://www.goldjournal.net/article/S0090-4295(16)30151-0/fulltext

2. Woo H, Chin PT, McNicholas TA, et al. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 2006;108:82–88.

http://onlinelibrary.wiley.com/wol1/doi/10.1111/

j. 1464-410X.2011.10342.x/abstract

3. Bardoli AD, Taylor ST W, Mahmalji W. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature. Aging Male 2017;Jun 13:1–6.

http://www.tandfonline.com/doi/abs/10.1080/136855 38.2017.1336531

4. Roehrborn G, Gange S, Shore ND, et al. Durability of the prostatic urethral lift: 2 year results of the L.I.F.T. Study. Urol Pract 2015;2:26–32.

http://linkinghub.elsevier.com/retrieve/pii/S2352077914001447